FDA Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alopecia Areata Immunology
Research from Oita University has provided new information about alopecia areata immunology
March 15th, 2007
Researchers detail in "In vivo levels of IL-4, IL-10, TGF-beta1 and IFN-gamma mRNA of the peripheral blood mononuclear cells in patients with alopecia areata in comparison to those in patients with atopic dermatitis," new data in alopecia areata. "Alopecia areata (AA) has been considered to be supported by an aberrant expression of IFN-gamma as a result of antigen dependent immune response. On the other hand, AA sometimes concurs with atopic diseases, although the mechanism of the concurrence is not clear," investigators in Oita, Japan report. "This study was designed to elucidate the immune status of AA and the similarity between AA and atopic dermatitis (AD) by...
Source: FDA Law Weekly (2007-03-15)
|
